1-15 of 34
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD
Charles Turck, PharmD, BCPS, BCCCP
Joel L. Young, MD
Bowel Urgency as a Key Symptom in Ulcerative Colitis
Medical Industry FeatureBowel Urgency as a Key Symptom in Ulcerative Colitis
Ehsan Navabi, MD
Christie Morrison, NP
Bowel Urgency as a Key Symptom in Crohn’s Disease
Medical Industry FeatureBowel Urgency as a Key Symptom in Crohn’s Disease
Partha Nandi, MD
Amy Stewart, CRNP
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Jennifer Caudle, DO, FACOFP
Greg Mattingly, MD
Helping Patients Stay on Track With Collaborative LDL-C Care
Medical Industry FeatureHelping Patients Stay on Track With Collaborative LDL-C Care
Barry D. Bertolet MD, FACC
Todd Sandroni PharmD
Pediatric Influenza: Risks, Realities, and Prevention
VacciNationPediatric Influenza: Risks, Realities, and Prevention
Jennifer Caudle, DO, FACOFP
Laura Sass, MD
- advertisement
Beyond the Flu: Safeguarding Older Adults Through Vaccination
VacciNationBeyond the Flu: Safeguarding Older Adults Through Vaccination
Jennifer Caudle, DO, FACOFP
Stephen Thomas, MD
Seeing the Full Picture of ADHD: Beyond Core Symptoms
Innovations In MedicineSeeing the Full Picture of ADHD: Beyond Core Symptoms
Andrew J. Cutler, MD
Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Predicting the Heart’s Future: Albuminuria as a CV Warning Sign
Conversations in CV Risk AssessmentPredicting the Heart’s Future: Albuminuria as a CV Warning Sign
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Heart Failure and Albuminuria: Connecting the Dots
Conversations in CV Risk AssessmentHeart Failure and Albuminuria: Connecting the Dots
Jennifer Caudle, DO, FACOFP
Robert J. Mentz, MD, FHFSA, FACC
- advertisement
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Long-Term Efficacy and Safety Data in Ulcerative Colitis
Medical Industry FeatureLong-Term Efficacy and Safety Data in Ulcerative Colitis
Erica Cohen, MD
Ana’s Story – A Real Patient Living With Ulcerative Colitis
Medical Industry FeatureAna’s Story – A Real Patient Living With Ulcerative Colitis
Ana, A Real Patient Living With Ulcerative Colitis
Lukasz Kwapisz, MD
